Interestingly, IL-6 is also upregulated (fold change 7.317) in the combination group, and we found that IL-6 together with increased compressive force led to enhancement of positive feedback that controls EMT and tumor progression via the Akt/GSK-3β/β-catenin signaling pathway. The gene discussed is AKT1; the disease is neoplasm.